State-of-the-art radionuclide imaging in cardiac transthyretin amyloidosis

被引：0

作者：

Vasvi Singh

Rodney Falk

Marcelo F. Di Carli

Marie Kijewski

Claudio Rapezzi

Sharmila Dorbala

机构：

[1] Brigham and Women’s Hospital,Division of Nuclear Medicine and Department of Radiology

[2] Brigham and Women’s Hospital,Cardiac Amyloidosis Program

[3] Alma Mater Studiorum,Cardiology, Department of Experimental, Diagnostic and Specialty Medicine

[4] University of Bologna,Cardiac Amyloidosis Program, Cardiovascular Division, Department of Medicine, Heart and Vascular Center, Division of Nuclear Medicine and Department of Radiology

[5] Brigham and Women’s Hospital and Harvard Medical School,undefined

来源：

Journal of Nuclear Cardiology | 2019年 / 26卷

关键词：

Amyloid heart disease; SPECT; PET; modalities; molecular imaging;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Cardiac amyloidosis, once considered untreatable, is now gaining well-deserved attention due to advances in imaging and the recent approval of targeted breakthrough therapies. In this paper, we discuss the role of radionuclide imaging in the evaluation and management of patients with the most common form of amyloidosis—cardiac transthyretin amyloidosis (ATTR). We provide a comprehensive summary of the literature interspersed with our institutional experience as appropriate, to deliver our perspective.

引用

页码：158 / 173

页数：15

共 50 条

[41] Transthyretin Amyloid Cardiomyopathy JACC State-of-the-Art Review
Ruberg, Frederick L.
Grogan, Martha
Hanna, Mazen
Kelly, Jeffery W.
Maurer, Mathew S.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (22) : 2872 - 2891
[42] CARDIAC TRANSPLANTATION - STATE-OF-THE-ART
MORAN, S
REVISTA MEDICA DE CHILE, 1990, 118 (01) : 73 - 78
[43] Radionuclide Imaging of Cardiac Amyloidosis: An Update and Future Aspects
Clerc, Olivier F.
Vijayakumar, Shilpa
Dorbala, Sharmila
SEMINARS IN NUCLEAR MEDICINE, 2024, 54 (05) : 717 - 732
[44] Cardiac markers: state-of-the-art
Jaffe, Allan
CLINICA CHIMICA ACTA, 2007, 381 (01) : 99 - 99
[45] Imaging modalities in early cardiac transthyretin amyloidosis: who is first?
Ney, Svenja
Pennig, Lenhard
Fassbach, Michael
Hohmann, Christopher
Pfister, Roman
CLINICAL RESEARCH IN CARDIOLOGY, 2023, 112 (03) : 450 - 453
[46] Diagnosis of cardiac involvement in systemic amyloidosis by state-of-the-art echocardiography: where are we now?
Mereles, Derliz
Aurich, Matthias
Greiner, Sebastian
Riffel, Johannes
Buss, Sebastian J.
Kristen, Arnt V.
Katus, Hugo A.
EXPERT OPINION ON ORPHAN DRUGS, 2016, 4 (06): : 639 - 648
[47] Non-invasive cardiac imaging methods in transthyretin amyloidosis
Rajtar-Salwa, Renata
Gebka, Adam
Petkow-Dimitrow, Pawel
KARDIOLOGIA POLSKA, 2019, 77 (02) : 234 - 234
[48] Imaging modalities in early cardiac transthyretin amyloidosis: who is first?
Svenja Ney
Lenhard Pennig
Michael Faßbach
Christopher Hohmann
Roman Pfister
Clinical Research in Cardiology, 2023, 112 : 450 - 453
[49] Multimodality imaging for diagnosis of subclinical hereditary transthyretin cardiac amyloidosis
Asif, Talal
Vij, Aviral
Radzik, Bartlomiej
Stern, Hudson
Simples, Patricia
Ghadiali, Quraish
Malhotra, Saurabh
JOURNAL OF NUCLEAR CARDIOLOGY, 2023, 30 (02) : 792 - 799
[50] Multimodality imaging for diagnosis of subclinical hereditary transthyretin cardiac amyloidosis
Talal Asif
Aviral Vij
Bartlomiej Radzik
Hudson Stern
Patricia Simples
Quraish Ghadiali
Saurabh Malhotra
Journal of Nuclear Cardiology, 2023, 30 : 792 - 799

← 1 2 3 4 5 →